EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human induced pluripotent stem cell-derived neural stem/progenitor cell therapy for spinal cord injury: preclinical advances and translational perspectives

Ryo Ogaki iD, Narihito Nagoshi, Hideyuki Okano iD, Masaya Nakamura

Stem Cells Translational Medicine · 09.01.2026 · 15 (1)

DOI: 10.1093/stcltm/szaf073 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 09.01.2026. Verfasst von Ryo Ogaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Induced Pluripotent Stem Cells, Neural Stem Cells, Stem Cell Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI) causes irreversible neurological damage and remains a major clinical challenge due to the lack of effective regenerative therapies. Human-induced pluripotent stem cells (hiPSCs) and their derivatives, hiPSC-derived neural stem/progenitor cells (hiPSC-NS/PCs), have demonstrated potential to promote neural repair and functional recovery. The world’s first clinical trial using hiPSC-NS/PCs in the subacute phase of SCI has already been initiated. In contrast, chronic SCI—despite accounting for the majority of clinical cases—remains difficult to treat due to pathological barriers such as widespread demyelination, cavitation, scar formation, and persistent inflammation. Recent efforts to overcome these obstacles include combinatorial strategies incorporating rehabilitation, biomaterial scaffolds, pharmacological adjuvants, and robotic-assisted therapy as well as gliogenic or regionally patterned hiPSC-NS/PCs. Preclinical models have demonstrated that such multifaceted approaches can enhance graft survival, axonal regeneration, and functional recovery. In this review, we provide an overview of the biological characteristics, mechanisms of action, and recent advances in preclinical and clinical research on hiPSC-NS/PCs transplantation for SCI. We also discuss future perspectives and challenges toward clinical application. Collectively, these efforts underscore the diverse, innovative, and translational potential of hiPSC-based regenerative medicine for SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesInduced Pluripotent Stem CellsNeural Stem CellsStem Cell TransplantationHumansAnimalsTranslational Research, BiomedicalNerve RegenerationRecovery of FunctionCell Differentiation

Stichwörter der Autor:innen

cell transplantationclinical translationinduced pluripotent stem cells (iPSCs)pluripotent stem cellsprogenitor cellsspinal cord injurystem/progenitor cell

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Keio University Regenerative Medicine Research Center, Kawasaki, Kanagawa 210-0821, Japan.

ORCID-Profile: Ryo Ogaki, Hideyuki Okano

Förderung

  • AMED

Zitieren

APA

Ogaki, R., Nagoshi, N., Okano, H., & Nakamura, M. (2026). Human induced pluripotent stem cell-derived neural stem/progenitor cell therapy for spinal cord injury: preclinical advances and translational perspectives. Stem Cells Translational Medicine, 15(1). https://doi.org/10.1093/stcltm/szaf073

Vancouver

Ogaki R, Nagoshi N, Okano H, Nakamura M. Human induced pluripotent stem cell-derived neural stem/progenitor cell therapy for spinal cord injury: preclinical advances and translational perspectives. Stem Cells Translational Medicine. 2026;15(1). doi:10.1093/stcltm/szaf073

BibTeX
@article{Ogaki2026,
  author = {Ogaki, Ryo and Nagoshi, Narihito and Okano, Hideyuki and Nakamura, Masaya},
  title = {Human induced pluripotent stem cell-derived neural stem/progenitor cell therapy for spinal cord injury: preclinical advances and translational perspectives},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1093/stcltm/szaf073}
}
Kostenlos starten →